洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR-TRC-13003012】The impact of home-visit, pharmacists-led medication management programme among single-living, hypertensive elderly with suboptimal compliance to multiple medications: a randomized controlled trial

基本信息
登记号

ChiCTR-TRC-13003012

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2013-01-22

临床申请受理号

/

靶点

/

适应症

Hypertension

试验通俗题目

The impact of home-visit, pharmacists-led medication management programme among single-living, hypertensive elderly with suboptimal compliance to multiple medications: a randomized controlled trial

试验专业题目

The impact of home-visit, pharmacists-led medication management programme among single-living, hypertensive elderly with suboptimal compliance to multiple medications: a randomized controlled trial

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

To assess the impact of a home visit medication management programme led by pharmacists in optimizing antihypertensive drug adherence among single-living elderly patients on multiple medications.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

其它

随机化

A simple random sampling design will be used. Each patient will be regarded as one unit of randomiza

盲法

/

试验项目经费来源

CUHK Research Committee Funding (Direct Grant)

试验范围

/

目标入组人数

150

实际入组人数

/

第一例入组时间

2012-06-01

试验终止时间

2013-12-31

是否属于一致性

/

入选标准

(1) Aged >=65 years; (2) Living alone with no continued support from family members or domestic helpers; (3) Taking at least two antihypertensive agents for management of arterial hypertension; (4) Assessed as having suboptimal antihypertensive compliance, as evaluated by the Morisky self-reported adherence questionnaire [19, 20]; (5) Currently attending medical clinics for refill of antihypertensive medications.;

排除标准

(1) Aged >=65 years; (2) Living alone with no continued support from family members or domestic helpers (3) Taking at least two antihypertensive agents for management of arterial hypertension; (4) Assessed as having suboptimal antihypertensive compliance, as evaluated by the Morisky self-reported adherence questionnaire [19, 20]; (5) Currently attending medical clinics for refill of antihypertensive medications.;

研究者信息
研究负责人姓名
请登录查看
试验机构

CUHK Research Committee Funding (Direct Grant)

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

The Chinese University of Hong Kong的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用

同适应症药物临床试验